Holen Sie sich die Stockscreener-App
13.18
0.08%
0.010
Handel nachbörslich:
13.10
-0.08
-0.61%
Schlusskurs vom Vortag:
$13.17
Offen:
$13.3
24-Stunden-Volumen:
1.41M
Relative Volume:
0.73
Marktkapitalisierung:
$3.29B
Einnahmen:
$475.68M
Nettoeinkommen (Verlust:
$77.81M
KGV:
42.34
EPS:
0.3113
Netto-Cashflow:
$160.32M
1W Leistung:
+1.54%
1M Leistung:
-0.90%
6M Leistung:
-21.92%
1J Leistung:
-21.13%
1-Tages-Spanne:
$12.99
$13.59
1-Wochen-Bereich:
$12.40
$14.05
52-Wochen-Spanne:
$11.02
$19.98
Cellebrite Di Ltd Stock (CLBT) Company Profile
Firmenname
Cellebrite Di Ltd
Sektor
Branche
Telefon
-
Adresse
-
Compare CLBT vs MSFT, ORCL, PLTR, CRWD, SNPS
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CLBT
Cellebrite Di Ltd
|
13.18 | 3.29B | 475.68M | 77.81M | 160.32M | 0.3113 |
MSFT
Microsoft Corp
|
418.57 | 3.11T | 318.27B | 125.22B | 72.92B | 16.79 |
ORCL
Oracle Corp
|
192.08 | 545.79B | 64.08B | 16.40B | -24.74B | 5.5698 |
PLTR
Palantir Technologies Inc
|
136.88 | 329.43B | 5.22B | 2.29B | 2.69B | 0.8876 |
CRWD
Crowdstrike Holdings Inc
|
663.46 | 165.00B | 4.81B | -181.85M | 1.24B | -0.7398 |
SNPS
Synopsys Inc
|
524.74 | 96.54B | 8.00B | 1.10B | 2.28B | 6.4708 |
Cellebrite Di Ltd Stock (CLBT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-03-28 | Bestätigt | Needham | Buy |
| 2024-03-13 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2024-02-16 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-07-19 | Eingeleitet | Craig Hallum | Buy |
| 2022-08-12 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-08-12 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2022-02-24 | Eingeleitet | JP Morgan | Overweight |
| 2022-02-11 | Eingeleitet | Deutsche Bank | Buy |
| 2021-12-02 | Eingeleitet | BofA Securities | Buy |
| 2021-10-21 | Eingeleitet | Citigroup | Buy |
Alle ansehen
Cellebrite Di Ltd Aktie (CLBT) Neueste Nachrichten
A Look At Cellebrite DI (CLBT) Valuation After Q1 2026 Earnings And New Growth Guidance - simplywall.st
Insider sale of 3,064 restricted shares (CLBT) reported to SEC - Stock Titan
5,673 RSUs to be sold by Cellebrite (NASDAQ: CLBT) after S-8 vesting - Stock Titan
CLBT - Intellectia AI
Is the DoD's CMMC Enforcement a Gold Rush for Cybersecurity Providers - Kavout
Earnings call transcript: Cellebrite Q1 2026 beats forecasts, stock rises By Investing.com - Investing.com Australia
BROWN CAPITAL MANAGEMENT LLC's Cellebrite DI Ltd(CLBT) Holding History - GuruFocus
Cellebrite (CLBT) CRO Jewell sells 12,658 shares tied to RSU tax obligations - Stock Titan
Cellebrite DI Ltd. (CLBT) Q1 2026 Earnings Call Transcript - Intellectia AI
Cellebrite DI Sees Federal Rebound as AI, Defense Tools Fuel New Growth - MarketBeat
Cellebrite DI Ltd. (CLBT) reports 31,728 vested RSUs; affiliate recent sales listed - Stock Titan
Cellebrite DI Ltd. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:CLBT) 2026-05-17 - Seeking Alpha
Cellebrite DI Ltd stock (IL0011384071): Q1 results highlight recurring revenue mix - AD HOC NEWS
Cellebrite DI (CLBT) Profitability Turnaround Tests Bullish Growth Narratives - simplywall.st
Cellebrite: Positive Q1 Results, But There Is Room For Margin Improvements - Seeking Alpha
Cellebrite Earnings Call Highlights AI-Fueled Growth - The Globe and Mail
Needham cuts Cellebrite stock price target on valuation to $15 - Investing.com UK
Cellebrite DI (CLBT) Valuation Check After Q1 Beat AI Uptake And FedRAMP High Authorization - Yahoo Finance
Cellebrite Q1 2026 Beat Fuels 99% Upside Case for CLBT Stock - TIKR.com
Cellebrite DI Ltd. (NASDAQ:CLBT) Q1 2026 Earnings Call Transcript - Insider Monkey
Needham cuts Cellebrite stock price target on valuation to $15 By Investing.com - Investing.com Australia
Cellebrite Posts Strong Q1 2026 Growth, Expands AI and Drone Forensics Portfolio - The Globe and Mail
Cellebrite Announces First-Quarter 2026 Results - GuruFocus
CLBT SEC FilingsCellebrite Di Ltd 10-K, 10-Q, 8-K Forms - Stock Titan
FedRAMP High Win And Mixed Q1 Results Might Change The Case For Investing In Cellebrite (CLBT) - simplywall.st
Earnings Call Summary | Cellebrite(CLBT.US) Q1 2026 Earnings Conference - Moomoo
Cellebrite outlines $510M-$513M Q2 ARR outlook as Genesis early access reaches 500+ users - MSN
Cellebrite (CLBT) CMO sells 228 shares tied to RSU tax obligations - Stock Titan
Cellebrite (CLBT) CRO sells 383 shares to cover RSU tax obligations - Stock Titan
Cellebrite (CLBT) president awarded 423,550 RSUs vesting through 2030 - Stock Titan
Cellebrite DI Q1 2026 EPS Tops Expectations by 20.0%, Revenue Up 19% - AlphaStreet
Cellebrite stock falls 4% despite beating first quarter estimates - Investing.com
Cellebrite Q1 2026 earnings preview - MSN
Cellebrite DI Ltd. (CLBT) Q1 earnings and revenues top estimates - MSN
Press releases provided by CNW - Techaeris
Cellebrite DI Q1 Earnings Call Highlights - MarketBeat
Earnings call transcript: Cellebrite Q1 2026 earnings beat estimates By Investing.com - Investing.com Canada
Cellebrite DI Q1 2026 Earnings Call Transcript - Benzinga
Cellebrite Shares Slip Despite First-Quarter Earnings Beat - Yahoo Finance
Cellebrite DI Ltd reports results for the quarter ended December 31Earnings Summary - TradingView
Cellebrite DI Releases Q1 2026 Financial Results - AlphaStreet
Cellebrite DI Ltd (NASDAQ:CLBT) Q1 Results Miss Revenue Target but Beat EPS - ChartMill
Cellebrite Reports Q1 2026 Results: ARR Reaches $493 Million, Up 21% Year-Over-Year - citybiz
Cellebrite DI Ltd. (CLBT) Q1 Earnings and Revenues Top Estimates - Yahoo Finance
Cellebrite DI : Investor Presentation May 2026 - marketscreener.com
Cellebrite DI : CLBT Q126 Historical Financial Tables and Supplemental Data - marketscreener.com
CELLEBRITE DI ($CLBT) Releases Q1 2026 Earnings - Quiver Quantitative
Cellebrite stock falls 4% despite beating first quarter estimates By Investing.com - Investing.com Nigeria
Cellebrite Q1 Adjusted Earnings, Revenue Rise; Issues Q2, 2026 Revenue Guidance; Shares Fall Pre-Bell - marketscreener.com
(CLBT) Cellebrite DI Expects 2026 Revenue Range $565M$571M, vs. FactSet Est of $568.5M - marketscreener.com
Cellebrite (NASDAQ: CLBT) posts Q1 2026 growth and issues 2026 guidance - Stock Titan
Finanzdaten der Cellebrite Di Ltd-Aktie (CLBT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.83%
1.66%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):